T Stamp Inc
Change company Symbol lookup
Select an option...
IDAI T Stamp Inc
VZ Verizon Communications Inc
CETX Cemtrex Inc
RNXT RenovoRx Inc
BNTX BioNTech SE
ARTW Art's Way Manufacturing Co Inc
ARIZU Arisz Acquisition Corp
OSH Oak Street Health Inc
LESL Leslie's Inc
AAPL Apple Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Information Technology : Software | Small Cap Blend
Company profile

T Stamp, Inc. is an artificial intelligence (AI) company. The Company develops and market’s identity authentication software solutions for enterprise partners and peer-to-peer (P2P) markets. It develops proprietary artificial intelligence driven solutions; researching and leveraging cutting edge technology including biometric science, cryptography, and data mining to deliver understanding identity and trust predictions while protecting the user’s privacy and identifying and defending against fraudulent identity attacks. The Company utilizes the cutting-edge power and agility of technologies, such as graphics processing unit (GPU), neural networks and edge computing to process data effectively for usage across industries, including banking/fintech, humanitarian and development services, biometrically secured email, know your customer/anti-money laundering compliance, government and law enforcement, P2P transactions, social media, sharing economy, real estate, travel, and healthcare.

Premarket

Last Trade
Delayed
$2.26
Change Since Close

Change Since Close

Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.

-0.136 (-5.68%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.40
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
16

10-day average volume:
16,383
16
Historical quotes & splits

AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors

4:33 pm ET January 10, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) shed 1.25% to $159.64 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.70% to 3,919.25 and the Dow Jones Industrial Average rising 0.56% to 33,704.10. This was the stock's second consecutive day of losses. AbbVie Inc. closed $16.27 below its 52-week high ($175.91), which the company reached on April 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.24% to $175.16 and Pfizer Inc. (PFE) fell 1.59% to $47.62. Trading volume (5.9 M) eclipsed its 50-day average volume of 5.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 10, 2023.

(END) Dow Jones Newswires

January 10, 2023 16:33 ET (21:33 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.

3rd Party Research Disclosure